+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Proton therapy for uveal melanoma in 43 juvenile patients: long-term results

Proton therapy for uveal melanoma in 43 juvenile patients: long-term results

Ophthalmology 121(4): 898-904

To examine the metastatic and survival rates, eye retention probability, and the visual outcomes of juvenile patients after proton beam radiotherapy (PBRT) for uveal melanoma (UM). Retrospective case-factor matched control study. Forty-three patients younger than 21 years treated with PBRT for UM were compared with 129 matched adult control patients. Information on patient demographics and clinical characteristics were recorded before and after treatment from patients' files. The control group was composed of adult patients (>21 years) matched for tumor size (largest tumor diameter, ±2 mm; height, ±2 mm) and anterior margin location (iris, ciliary body, pre-equatorial or postequatorial choroid). For each juvenile patient, 3 adults were selected. Comparing outcomes of juvenile and adult patients in terms of metastatic and eye retention rates using the log-rank statistic, relative survival using the Hakulinen method, as well as their visual outcomes. Forty-three juvenile and 129 control cases were reviewed. The metastatic rate at 10 years was significantly lower in juvenile UM patients than in adult controls (11% vs. 34%; P <0.01), with an associated relative survival rate of 93% versus 65% (P = 0.02). Six juvenile patients (14%) demonstrated metastases. One patient underwent enucleation because of a presumed local tumor recurrence and 4 additional patients underwent enucleation because of complications (9.3%). In the adult control group, 27% (n = 35) of matched patients demonstrated metastases, there were 2 cases of local recurrence, and 16% (n = 21) underwent enucleation because of complications. A visual acuity of more than 0.10 was maintained in most cases, without any significant differences before or after treatment observed between both groups. After PBRT, metastatic and survival rates are significantly better for juvenile than for adult patients with UM. Clinically, juvenile and adult eyes react similarly to PBRT, with patients having a comparable eye retention probability and maintaining a useful level of vision in most cases. This is the largest case-control study of proton therapy in juvenile eyes to date and further validates PBRT as an appropriate conservative treatment for UM in patients younger than 21 years.

(PDF emailed within 0-6 h: $19.90)

Accession: 055260529

Download citation: RISBibTeXText

PMID: 24405742

DOI: 10.1016/j.ophtha.2013.10.032

Related references

Long-term Risk of Melanoma-Related Mortality for Patients With Uveal Melanoma Treated With Proton Beam Therapy. JAMA Ophthalmology 133(7): 792-796, 2015

Long-term results after proton irradiation of uveal melanoma. Investigative Ophthalmology & Visual Science 38(4 PART 1-2): S486, 1997

Uveal melanoma: quantitative evaluation of diffusion-weighted MR imaging in the response assessment after proton-beam therapy, long-term follow-up. La Radiologia Medica: -, 2016

Proton beam radiotherapy for uveal melanoma: results of Curie Institut-Orsay proton therapy center (ICPO). International Journal of Radiation Oncology, Biology, Physics 65(3): 780-787, 2006

Trabeculectomy in patients with uveal melanoma after proton beam therapy. Graefe's Archive for Clinical and Experimental Ophthalmology 254(7): 1379-1385, 2016

Long-term results of proton beam irradiated uveal melanomas. Ophthalmology 94(4): 349-353, 1987

Long-term results of cobalt 60 curietherapy for uveal melanoma. Journal Francais D'ophtalmologie 21(5): 333-344, 1998

Long term results of helium ion radiotherapy for uveal melanoma. International Journal of Radiation Oncology, Biology, Physics 17(SUPPL 1): 190, 1989

Long-term results of helium ion irradiation of uveal melanoma. International Journal of Radiation Oncology, Biology, Physics 19(3): 613-618, 1990

Long-term results of iodine 125 irradiation of uveal melanoma. Ophthalmology 99(5): 767-73; Discussion 774, 1992

Cataract development in patients treated with proton beam therapy for uveal melanoma. Graefe's Archive for Clinical and Experimental Ophthalmology 254(8): 1625-1630, 2016

Posterior uveal melanoma in young patients treated with proton beam therapy. Retina 30(8): 1267-1271, 2010

Long-term follow-up after uveal melanoma charged particle therapy. Transactions of the American Ophthalmological Society 95(): 171-87; Discussion 187-91, 1997

Antiangiogenic or Corticosteroid Treatment in Patients With Radiation Maculopathy After Proton Beam Therapy for Uveal Melanoma. American Journal of Ophthalmology 168(): 31-39, 2016

Very long-term prognosis of patients with malignant uveal melanoma. Investigative Ophthalmology & Visual Science 44(11): 4651-4659, 2003